Tsukigawa Kenji 月川健士

… Alternative Names

TSUKIGAWA Kenji 月川健士

Less

Researcher Number	60772027
Other IDs
Affiliation (Current)	2022: 崇城大学, 薬学部, 講師
Affiliation (based on the past Project Information) *help	2020 – 2021: 崇城大学, 薬学部, 助教 2019: 九州保健福祉大学, 薬学部, 助教
Review Section/Research Field	Principal Investigator Basic Section 47060:Clinical pharmacy-related
Keywords	Principal Investigator アルブミン / ドラッグデリバリーシステム / がん / ピラルビシン / 酸性環境応答性 / 一酸化窒素 / EPR効果 / 高分子化抗がん剤 / 抗がん効果

高分子化抗がん剤のがん組織集積性を増強するがん指向性NO徐放剤の開発Principal Investigator
- Principal Investigator
  
  月川健士
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Sojo University
Synthesis and therapeutic effect of macromolecular antitumor drug, pH-sensitive human serum albumin conjugates of pirarubicinPrincipal Investigator
- Principal Investigator
  
  TSUKIGAWA Kenji
- Project Period (FY)
  2019 – 2020
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Sojo University
  Kyushu University of Health and Welfare

All 2021 2020 2019

All Journal Article Presentation

[Journal Article] Synthesis and In Vitro Assessment of pH-Sensitive Human Serum Albumin Conjugates of Pirarubicin2020
- Author(s)
  Tsukigawa Kenji、Imoto Shuhei、Yamasaki Keishi、Nishi Koji、Tsutsumi Toshihiko、Yokoyama Shoko、Ishima Yu、Otagiri Masaki
- Journal Title
  
  Pharmaceuticals
  
  Volume: 14 Pages: 22-22
- DOI
  10.3390/ph14010022
- NAID
  120007174425
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06810, KAKENHI-PROJECT-19K16467
[Presentation] 酸性環境応答性を有するアルブミン結合型抗がん剤の作製と評価2021
- Author(s)
  月川健士、井本修平、西弘二、堤敏彦、横山祥子、小田切優樹、山﨑啓之
- Organizer
  日本薬学会第141年会
- Data Source
  KAKENHI-PROJECT-19K16467
[Presentation] 酸性環境応答性を有するアルブミン結合型高分子化抗がん剤の設計と評価2020
- Author(s)
  月川健士、井本修平、山﨑啓之、堤敏彦、横山祥子、小田切優樹
- Organizer
  日本薬学会第140年会
- Data Source
  KAKENHI-PROJECT-19K16467
[Presentation] 副作用のないがん治療を目指した高分子型抗がん剤の研究開発2019
- Author(s)
  月川健士
- Organizer
  第一回宮崎県北サイエンスフォーラム
- Data Source
  KAKENHI-PROJECT-19K16467

1. 小田切優樹

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Tsukigawa Kenji 月川健士

TSUKIGAWA Kenji 月川健士

Research Projects

Research Products

Co-Researchers

高分子化抗がん剤のがん組織集積性を増強するがん指向性NO徐放剤の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Synthesis and therapeutic effect of macromolecular antitumor drug, pH-sensitive human serum albumin conjugates of pirarubicinPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Synthesis and In Vitro Assessment of pH-Sensitive Human Serum Albumin Conjugates of Pirarubicin2020

Author(s)

Journal Title

DOI

NAID

Data Source

[Presentation] 酸性環境応答性を有するアルブミン結合型抗がん剤の作製と評価2021

Author(s)

Organizer

Data Source

[Presentation] 酸性環境応答性を有するアルブミン結合型高分子化抗がん剤の設計と評価2020

Author(s)

Organizer

Data Source

[Presentation] 副作用のないがん治療を目指した高分子型抗がん剤の研究開発2019

Author(s)

Organizer

Data Source

Tsukigawa Kenji 月川 健士

TSUKIGAWA Kenji 月川 健士

Research Projects

Research Products

Co-Researchers

高分子化抗がん剤のがん組織集積性を増強するがん指向性NO徐放剤の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Synthesis and therapeutic effect of macromolecular antitumor drug, pH-sensitive human serum albumin conjugates of pirarubicinPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Synthesis and In Vitro Assessment of pH-Sensitive Human Serum Albumin Conjugates of Pirarubicin2020

Author(s)

Journal Title

DOI

NAID

Data Source

[Presentation] 酸性環境応答性を有するアルブミン結合型抗がん剤の作製と評価2021

Author(s)

Organizer

Data Source

[Presentation] 酸性環境応答性を有するアルブミン結合型高分子化抗がん剤の設計と評価2020

Author(s)

Organizer

Data Source

[Presentation] 副作用のないがん治療を目指した 高分子型抗がん剤の研究開発2019

Author(s)

Organizer

Data Source

Tsukigawa Kenji 月川健士

TSUKIGAWA Kenji 月川健士

[Presentation] 副作用のないがん治療を目指した高分子型抗がん剤の研究開発2019